GSK Aktie
22,93
EUR
+0,28
EUR
+1,24
%
19,16
GBP
+0,15
GBP
+0,76
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Diese Analysten bewerten die GSK-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 17,00 GBP | - | 03.11.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 22,00 GBP | - | 03.11.2026 | |
| Goldman Sachs Group Inc. | 18,50 GBP | - | 02.11.2026 | |
| Deutsche Bank AG | 20,00 GBP | - | 02.11.2026 | |
| Bernstein Research | 30,04 GBP | - | 02.11.2026 | |
| DZ BANK | - | - | 30.10.2026 | |
| Barclays Capital | 17,50 GBP | - | 30.10.2026 | |
| RBC Capital Markets | 19,25 GBP | - | 29.10.2026 | |
| UBS AG | 19,40 GBP | - | 29.10.2026 | |
| Jefferies & Company Inc. | 21,00 GBP | - | 29.10.2026 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Bayer | 7 | 2 | 0 | 58,31 EUR | +3,02% |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 6 | 2 | 20,52 GBP | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 3 | 5 | 0 | 149,00 EUR | +0,03% |
| Novartis AG | 1 | 7 | 2 | 123,90 CHF | -7,76% |
| Perrigo Company | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 6 | 1 | 28,43 USD | -1,01% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 5 | 0 | 94,11 EUR | +6,94% |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |